Author Correction: Building a global alliance of biofoundries

Nathan Hillson, Mark Caddick, Yizhi Cai, Jose A. Carrasco, Matthew Wook Chang, Natalie C. Curach, David J. Bell, Rosalind Le Feuvre, Douglas C. Friedman, Xiongfei Fu, Nicholas D. Gold, Markus J. Herrgård, Maciej B. Holowko, James R. Johnson, Richard A. Johnson, Jay D. Keasling, Richard I. Kitney, Akihiko Kondo, Chenli Liu, Vincent J. J. Martin, Filippo Menolascina, Chiaki Ogino, Nicola J. Patron, Marilene Pavan, Chueh Loo Poh, Isak S. Pretorius, Susan J. Rosser, Nigel S. Scrutton, Marko Storch, Hille Tekotte, Evelyn Travnik, Claudia E. Vickers, Wen Shan Yew, Yingjin Yuan, Huimin Zhao and Paul S. Freemont ()
Additional contact information
Nathan Hillson: DOE Agile BioFoundry
Mark Caddick: GeneMill, Institute of Integrative Biology, University of Liverpool
Yizhi Cai: SYNBIOCHEM, Manchester Institute of Biotechnology and School of Chemistry, University of Manchester
Jose A. Carrasco: Earlham Institute, Norwich Research Park
Matthew Wook Chang: NUS Synthetic Biology for Clinical and Technological Innovation (SynCTI), Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore
Natalie C. Curach: Bioplatforms Australia, Research Park Drive, Macquarie University
David J. Bell: London DNA Foundry, Imperial College Translation & Innovation Hub, White City Campus
Rosalind Le Feuvre: SYNBIOCHEM, Manchester Institute of Biotechnology and School of Chemistry, University of Manchester
Douglas C. Friedman: Engineering Biology Research Consortium (EBRC)
Xiongfei Fu: Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences
Nicholas D. Gold: Centre for Applied Synthetic Biology, Concordia University, Montreal
Markus J. Herrgård: The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark
Maciej B. Holowko: CSIRO Synthetic Biology Future Science Platform
James R. Johnson: GeneMill, Institute of Integrative Biology, University of Liverpool
Richard A. Johnson: Global Helix LLC, BioBricks Foundation, and Engineering Biology Research Consortium (EBRC)
Jay D. Keasling: DOE Agile BioFoundry
Richard I. Kitney: London DNA Foundry, Imperial College Translation & Innovation Hub, White City Campus
Akihiko Kondo: Graduate School of Science, Technology, and Innovation, Kobe University
Chenli Liu: Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences
Vincent J. J. Martin: Centre for Applied Synthetic Biology, Concordia University, Montreal
Filippo Menolascina: UK Centre for Mammalian Synthetic Biology SynthSys, School of Biological Sciences, University of Edinburgh
Chiaki Ogino: Graduate School of Science, Technology, and Innovation, Kobe University
Nicola J. Patron: Earlham Institute, Norwich Research Park
Marilene Pavan: DAMP Lab, Biological Design Center, Boston University
Chueh Loo Poh: NUS Synthetic Biology for Clinical and Technological Innovation (SynCTI), Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore
Isak S. Pretorius: Macquarie University
Susan J. Rosser: UK Centre for Mammalian Synthetic Biology SynthSys, School of Biological Sciences, University of Edinburgh
Nigel S. Scrutton: SYNBIOCHEM, Manchester Institute of Biotechnology and School of Chemistry, University of Manchester
Marko Storch: London DNA Foundry, Imperial College Translation & Innovation Hub, White City Campus
Hille Tekotte: UK Centre for Mammalian Synthetic Biology SynthSys, School of Biological Sciences, University of Edinburgh
Evelyn Travnik: The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark
Claudia E. Vickers: CSIRO Synthetic Biology Future Science Platform
Wen Shan Yew: NUS Synthetic Biology for Clinical and Technological Innovation (SynCTI), Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore
Yingjin Yuan: Frontier Science Center for Synthetic Biology (MOE), TianjinUniversity
Huimin Zhao: Illinois Biological Foundry for Advanced Biomanufacturing (iBioFAB), University of Illinois at Urbana-Champaign
Paul S. Freemont: London DNA Foundry, Imperial College Translation & Innovation Hub, White City Campus

Nature Communications, 2019, vol. 10, issue 1, 1-2

Abstract: The original version of this Comment contained errors in the legend of Figure 2, in which the locations of the fifteenth and sixteenth GBA members were incorrectly given as ‘(15) Australian Genome Foundry, Macquarie University; (16) Australian Foundry for Advanced Biomanufacturing, University of Queensland.’. The correct version replaces this with ‘(15) Australian Foundry for Advanced Biomanufacturing (AusFAB), University of Queensland and (16) Australian Genome Foundry, Macquarie University’. This has been corrected in both the PDF and HTML versions of the Comment.

Date: 2019
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.nature.com/articles/s41467-019-10862-1 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-10862-1

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-019-10862-1

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().